Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2002
06/13/2002WO2002046765A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
06/13/2002WO2002046763A1 Method of identifying compounds capable of acting as agonists or antagonists of g-protein coupled receptors
06/13/2002WO2002046753A1 Functional dna array
06/13/2002WO2002046751A2 Methods of predicting chemotherapy response
06/13/2002WO2002046750A2 Methods of predicting chemotherapy response
06/13/2002WO2002046749A2 Screening method for identifying compounds that selectively induce interferon alpha
06/13/2002WO2002046483A2 Silver stain removal from dna detection chips by cyanide etching or sonication
06/13/2002WO2002046477A2 Endogenous retroviruses up-regulated in prostate cancer
06/13/2002WO2002046476A2 Genotyping using partially-complementary probes
06/13/2002WO2002046475A2 Method of detecting and treating tuberous sclerosis complex associated disorders
06/13/2002WO2002046472A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
06/13/2002WO2002046471A2 Methods and compositions for the identification, assessment and therapy of human cancers
06/13/2002WO2002046470A2 Testing endosymbiont cellular organelles and compounds identifiable therewith
06/13/2002WO2002046469A1 Method of detecting abnormal gene
06/13/2002WO2002046468A2 Method for maldi-tof-ms analysis and/or sequencing of oligonucleotides
06/13/2002WO2002046467A2 Gene expression profiling of primary breast carcinomas using arrays of candidate genes
06/13/2002WO2002046466A2 Complexes of brca and stat polypeptides and methods of use in the detection and treatment of cancer
06/13/2002WO2002046465A2 Method for identification of genes involved in specific diseases
06/13/2002WO2002046464A2 Ligand detection method
06/13/2002WO2002046463A2 Nucleic acid extraction method and kit
06/13/2002WO2002046462A2 Functional genetic variants of matrix metalloproteinases (nmps)
06/13/2002WO2002046461A2 Method for identifying modulators of transcription
06/13/2002WO2002046460A2 Method for detecting risk of atherosclerosis
06/13/2002WO2002046459A2 Method for the determination of at least one functional polymorphism in the nucleotide sequence of a preselected candidate gene and its applications
06/13/2002WO2002046458A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
06/13/2002WO2002046457A2 Method for encoding hybridization probes
06/13/2002WO2002046456A1 Isothermal amplification of nucleic acids on a solid support
06/13/2002WO2002046454A2 Diagnosis of diseases associated with angiogenesis by determining the methylation of genes associated with angiogenesis
06/13/2002WO2002046453A2 Method and kit for identification of nucleic acid modification enzymes and inhibitors thereof
06/13/2002WO2002046452A2 Method for quantifying cytosine methylations in genomic dna that is amplified in a complex manner
06/13/2002WO2002046451A2 Methods for the identification of inhibitors of cysteine syhthase in plants
06/13/2002WO2002046449A2 Selection of catalytic nucleic acids targeted to infectious agents
06/13/2002WO2002046448A2 Methods and devices for the quantitative detection of prostate specific membrane antigen and other prostatic markers
06/13/2002WO2002046447A2 Methods for identifying nucleotides at defined positions in target nucleic acids
06/13/2002WO2002046426A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
06/13/2002WO2002046419A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
06/13/2002WO2002046418A2 Lipid-associated molecules
06/13/2002WO2002046415A2 Polynucleotide and polypeptide sequences of putative transporters and ion channells
06/13/2002WO2002046414A2 Human g-protein coupled receptor expressed highly in kidney
06/13/2002WO2002046412A2 Regulation of angiogenesis with zinc finger proteins
06/13/2002WO2002046411A2 Intestinal proteins
06/13/2002WO2002046409A2 Proteins and nucleic acids encoding same
06/13/2002WO2002046407A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/13/2002WO2002046406A2 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
06/13/2002WO2002046404A2 Schizophrenia-related voltage-gated ion channel gene and protein
06/13/2002WO2002046393A1 Method of identifying nucleotide polymorphism
06/13/2002WO2002046387A2 Plant derived hydroxy phenyl pyruvate dioxygenases (hppd) resistant against triketone herbicides and transgenic plants containing these dioxygenases
06/13/2002WO2002046386A2 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
06/13/2002WO2002046385A2 Enzymes
06/13/2002WO2002046384A2 Kinases and phosphatases sequences, and use thereof
06/13/2002WO2002046383A2 Protein modification and maintenance molecules
06/13/2002WO2002046382A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/13/2002WO2002046381A2 Method for the prevention or reduction of haze in beverages
06/13/2002WO2002046372A1 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
06/13/2002WO2002046369A2 Yeast-based assays involving gpcrs
06/13/2002WO2002046367A2 Antisense modulation of cellular apoptosis susceptibility gene expression
06/13/2002WO2002046364A2 Genes associated with mechanical stress, expression products therefrom, and uses thereof
06/13/2002WO2002046363A2 Improved methods for gene expression monitoring on electronic microarrays
06/13/2002WO2002046353A2 Self-spreading microbiological culture device
06/13/2002WO2002046230A2 G-protein coupled receptors
06/13/2002WO2002046224A2 Compositions and methods relating to lung specific genes and proteins
06/13/2002WO2002046223A2 Compositions and methods related to the minn1 tumor suppressor gene and protein
06/13/2002WO2002046216A2 Human sprouty-4 polypeptide
06/13/2002WO2002046214A2 Immunomodulatory protein derived from the yaba monkey tumor virus
06/13/2002WO2002046212A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/13/2002WO2002046147A2 Perturbed membrane-binding compounds
06/13/2002WO2002045842A1 Linear array devices for detecting an analyte or for screening
06/13/2002WO2002045835A2 Microelectronic arrays for cell-based functional genomics / high throughput phenotyping by electrokinetic assembly
06/13/2002WO2002045736A1 Methods for improved diagnosis and treatment of mycobacterial infections
06/13/2002WO2002045659A2 Novel therapeutics for heart failure and aging
06/13/2002WO2002045570A2 Methods and compositions for the diagnosis and treatment of viral disease using 55092
06/13/2002WO2002045524A2 Prolyl endoprotease from aspergillus niger
06/13/2002WO2002045523A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
06/13/2002WO2002045506A1 Drug screening system
06/13/2002WO2002033402A3 Establishment of biological cut-off values for predicting resistance to therapy
06/13/2002WO2002031210B1 Altered hox and wnt7a expression in human lung cancer
06/13/2002WO2002026929A3 Kini-3 motor protein and methods for its use
06/13/2002WO2002026770A3 Haplotypes of the admr gene
06/13/2002WO2002026768A3 Haplotypes of the por gene
06/13/2002WO2002021098A3 A method for identifying polymorphisms
06/13/2002WO2002020416A3 Polyhydroxyalkanoate levels as an indicator of bioreactor health
06/13/2002WO2002014535A3 Electrochemical strip test for small volumes
06/13/2002WO2002014534A3 Method of amplifying nucleic acids providing means for strand separation and universal sequence tags
06/13/2002WO2002012339A3 Sequences for integrin alpha-8
06/13/2002WO2002011886A3 Apparatus for diagnostic assays
06/13/2002WO2002010404A3 Regulation of human masp-like serine protease
06/13/2002WO2002008763A3 Immunosensor
06/13/2002WO2002003072A3 A method for extracting quantitative information relating to interactions between cellular components
06/13/2002WO2002002054A3 Methods and compositions for the diagnosis of schizophrenia
06/13/2002WO2001098350A3 Compositions comprising net-4 modulations and their use for treating neoplastic disease
06/13/2002WO2001096377A3 Vaccine for congenital tremors in pigs
06/13/2002WO2001094415A3 Nuclear hormone receptor
06/13/2002WO2001094362A3 Haplotypes of the acp2 gene
06/13/2002WO2001090188A3 Receptor-based interaction trap
06/13/2002WO2001077372A3 Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
06/13/2002WO2001060860A3 Genes differentially expressed in human prostate cancer and their use
06/13/2002WO2001059103A3 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
06/13/2002WO2001057242A3 Methods of protein destabilization and uses thereof
06/13/2002WO2001053526A3 Homogenous assay of duplex or triplex hybridization by means of multiple measurements under varied conditions
06/13/2002WO2001051663A3 Integrated systems and methods for diversity generation and screening
1 ... 2289 2290 2291 2292 2293 2294 2295 2296 2297 2298 2299 2300 2301 2302 2303 2304 2305 2306 2307 2308 2309 ... 3003